nodes	percent_of_prediction	percent_of_DWPC	metapath
Desogestrel—PGR—Nuclear Receptors—RARB—head and neck cancer	0.0452	0.0526	CbGpPWpGaD
Desogestrel—PGR—Nuclear signaling by ERBB4—YAP1—head and neck cancer	0.0403	0.0469	CbGpPWpGaD
Desogestrel—PGR—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.0357	0.0416	CbGpPWpGaD
Desogestrel—ESR1—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.032	0.0373	CbGpPWpGaD
Desogestrel—SHBG—Nongenotropic Androgen signaling—MAPK3—head and neck cancer	0.0297	0.0345	CbGpPWpGaD
Desogestrel—SHBG—Nongenotropic Androgen signaling—MAPK1—head and neck cancer	0.0282	0.0329	CbGpPWpGaD
Desogestrel—ESR1—Nuclear Receptors—RARB—head and neck cancer	0.0265	0.0309	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—XRCC1—head and neck cancer	0.0257	0.0299	CbGpPWpGaD
Desogestrel—SHBG—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.0245	0.0285	CbGpPWpGaD
Desogestrel—ESR1—Nuclear signaling by ERBB4—YAP1—head and neck cancer	0.0236	0.0275	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—TGFA—head and neck cancer	0.0228	0.0265	CbGpPWpGaD
Desogestrel—SHBG—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.0227	0.0264	CbGpPWpGaD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.021	0.0244	CbGpPWpGaD
Desogestrel—SHBG—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.02	0.0233	CbGpPWpGaD
Desogestrel—PGR—Cellular roles of Anthrax toxin—MAPK3—head and neck cancer	0.0159	0.0185	CbGpPWpGaD
Desogestrel—PGR—Cellular roles of Anthrax toxin—MAPK1—head and neck cancer	0.0151	0.0176	CbGpPWpGaD
Desogestrel—ESR1—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.0149	0.0173	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—YAP1—head and neck cancer	0.0136	0.0158	CbGpPWpGaD
Desogestrel—ESR1—Estrogen signaling pathway—BCL2—head and neck cancer	0.0127	0.0148	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.0127	0.0148	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.0117	0.0136	CbGpPWpGaD
Desogestrel—Breast cancer—Docetaxel—head and neck cancer	0.0107	0.0762	CcSEcCtD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—head and neck cancer	0.00862	0.01	CbGpPWpGaD
Desogestrel—ESR1—Estrogen signaling pathway—MAPK1—head and neck cancer	0.00855	0.00995	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—BCL2L1—head and neck cancer	0.00852	0.00992	CbGpPWpGaD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.00819	0.00953	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.008	0.00931	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—YAP1—head and neck cancer	0.00796	0.00926	CbGpPWpGaD
Desogestrel—Neoplasm—Vinblastine—head and neck cancer	0.00746	0.0531	CcSEcCtD
Desogestrel—ESR1—Estrogen signaling pathway—PIK3CA—head and neck cancer	0.00742	0.00864	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00729	0.00848	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—BCL2L1—head and neck cancer	0.00703	0.00818	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.00693	0.00806	CbGpPWpGaD
Desogestrel—Neoplasm—Hydroxyurea—head and neck cancer	0.00681	0.0484	CcSEcCtD
Desogestrel—ESR1—FOXM1 transcription factor network—CCND1—head and neck cancer	0.00673	0.00784	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00663	0.00771	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—RARB—head and neck cancer	0.00617	0.00718	CbGpPWpGaD
Desogestrel—ESR1—Estrogen signaling pathway—AKT1—head and neck cancer	0.00606	0.00706	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—BCL2—head and neck cancer	0.00598	0.00696	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—YAP1—head and neck cancer	0.00561	0.00653	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.00546	0.00635	CbGpPWpGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.00513	0.00597	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—CCND1—head and neck cancer	0.00513	0.00597	CbGpPWpGaD
Desogestrel—Breast disorder—Hydroxyurea—head and neck cancer	0.00494	0.0351	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.00491	0.00572	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.00491	0.00572	CbGpPWpGaD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.00481	0.00559	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—IL2—head and neck cancer	0.0047	0.00547	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.00467	0.00544	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—IL2—head and neck cancer	0.00459	0.00534	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—CCND1—head and neck cancer	0.00458	0.00533	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—CCND1—head and neck cancer	0.00447	0.00521	CbGpPWpGaD
Desogestrel—ESR1—LKB1 signaling events—TP53—head and neck cancer	0.00435	0.00506	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.00432	0.00503	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—PTEN—head and neck cancer	0.00432	0.00503	CbGpPWpGaD
Desogestrel—Weight increased—Hydroxyurea—head and neck cancer	0.0043	0.0306	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—CCND1—head and neck cancer	0.00423	0.00493	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—MAPK3—head and neck cancer	0.00423	0.00492	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—MAPK1—head and neck cancer	0.00403	0.00468	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00398	0.00463	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—PTEN—head and neck cancer	0.00396	0.0046	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.00394	0.00459	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.00382	0.00444	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—MAPK3—head and neck cancer	0.00378	0.00439	CbGpPWpGaD
Desogestrel—Fluid retention—Docetaxel—head and neck cancer	0.00371	0.0264	CcSEcCtD
Desogestrel—Alopecia—Vinblastine—head and neck cancer	0.00366	0.026	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—STAT3—head and neck cancer	0.00365	0.00425	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—RARB—head and neck cancer	0.00362	0.00421	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—MAPK1—head and neck cancer	0.00359	0.00418	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—EGFR—head and neck cancer	0.00359	0.00418	CbGpPWpGaD
Desogestrel—Neoplasm—Docetaxel—head and neck cancer	0.00354	0.0251	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—MAPK3—head and neck cancer	0.00349	0.00406	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—MAPK3—head and neck cancer	0.00338	0.00393	CbGpPWpGaD
Desogestrel—Alopecia—Hydroxyurea—head and neck cancer	0.00334	0.0237	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—MAPK1—head and neck cancer	0.00332	0.00387	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—YAP1—head and neck cancer	0.00329	0.00383	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.00328	0.00382	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.00325	0.00378	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—MAPK1—head and neck cancer	0.00322	0.00374	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—EGFR—head and neck cancer	0.00322	0.00374	CbGpPWpGaD
Desogestrel—Hypertension—Vinblastine—head and neck cancer	0.00312	0.0221	CcSEcCtD
Desogestrel—PGR—Gene Expression—RARB—head and neck cancer	0.00297	0.00346	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—TP53—head and neck cancer	0.00295	0.00343	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.00282	0.00328	CbGpPWpGaD
Desogestrel—Migraine—Docetaxel—head and neck cancer	0.00279	0.0199	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—PIK3CA—head and neck cancer	0.00279	0.00325	CbGpPWpGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00278	0.0198	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.00272	0.00317	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—YAP1—head and neck cancer	0.0027	0.00314	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—HRAS—head and neck cancer	0.00267	0.0031	CbGpPWpGaD
Desogestrel—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00263	0.0187	CcSEcCtD
Desogestrel—Skin disorder—Hydroxyurea—head and neck cancer	0.00261	0.0185	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—HRAS—head and neck cancer	0.00258	0.00301	CbGpPWpGaD
Desogestrel—Breast disorder—Docetaxel—head and neck cancer	0.00257	0.0182	CcSEcCtD
Desogestrel—ESR1—Regulation of Telomerase—AKT1—head and neck cancer	0.00255	0.00296	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.00253	0.00294	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—KISS1—head and neck cancer	0.00248	0.00289	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.00242	0.00281	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00241	0.0171	CcSEcCtD
Desogestrel—Alopecia—Fluorouracil—head and neck cancer	0.0024	0.0171	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—AKT1—head and neck cancer	0.00236	0.00274	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.00234	0.00272	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.00233	0.00272	CbGpPWpGaD
Desogestrel—Abdominal pain—Vinblastine—head and neck cancer	0.00233	0.0166	CcSEcCtD
Desogestrel—ESR1—Signaling by ERBB4—PTEN—head and neck cancer	0.00232	0.0027	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00232	0.0165	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—AKT1—head and neck cancer	0.00228	0.00265	CbGpPWpGaD
Desogestrel—Weight increased—Docetaxel—head and neck cancer	0.00223	0.0159	CcSEcCtD
Desogestrel—Weight decreased—Docetaxel—head and neck cancer	0.00222	0.0158	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.00222	0.00258	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.00221	0.00258	CbGpPWpGaD
Desogestrel—Hypersensitivity—Vinblastine—head and neck cancer	0.00217	0.0154	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.00211	0.00245	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—GRP—head and neck cancer	0.00204	0.00238	CbGpPWpGaD
Desogestrel—Diarrhoea—Vinblastine—head and neck cancer	0.00202	0.0143	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.002	0.00233	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—STAT6—head and neck cancer	0.00198	0.00231	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—MAPK3—head and neck cancer	0.00198	0.00231	CbGpPWpGaD
Desogestrel—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00198	0.0141	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.00193	0.00225	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.0019	0.00221	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.0019	0.00221	CbGpPWpGaD
Desogestrel—Nervous system disorder—Fluorouracil—head and neck cancer	0.0019	0.0135	CcSEcCtD
Desogestrel—ESR1—Signaling by ERBB4—MAPK1—head and neck cancer	0.00189	0.0022	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—EGFR—head and neck cancer	0.00189	0.0022	CbGpPWpGaD
Desogestrel—Vomiting—Vinblastine—head and neck cancer	0.00187	0.0133	CcSEcCtD
Desogestrel—Erythema multiforme—Docetaxel—head and neck cancer	0.00186	0.0132	CcSEcCtD
Desogestrel—Headache—Vinblastine—head and neck cancer	0.00185	0.0131	CcSEcCtD
Desogestrel—Diarrhoea—Hydroxyurea—head and neck cancer	0.00184	0.0131	CcSEcCtD
Desogestrel—Eye disorder—Docetaxel—head and neck cancer	0.00184	0.013	CcSEcCtD
Desogestrel—Immune system disorder—Docetaxel—head and neck cancer	0.00177	0.0126	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—YAP1—head and neck cancer	0.00176	0.00204	CbGpPWpGaD
Desogestrel—Nausea—Vinblastine—head and neck cancer	0.00175	0.0124	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.00175	0.00203	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—RARB—head and neck cancer	0.00174	0.00203	CbGpPWpGaD
Desogestrel—Alopecia—Docetaxel—head and neck cancer	0.00174	0.0123	CcSEcCtD
Desogestrel—Mental disorder—Docetaxel—head and neck cancer	0.00172	0.0122	CcSEcCtD
Desogestrel—Malnutrition—Docetaxel—head and neck cancer	0.00171	0.0122	CcSEcCtD
Desogestrel—Vomiting—Hydroxyurea—head and neck cancer	0.00171	0.0121	CcSEcCtD
Desogestrel—Rash—Hydroxyurea—head and neck cancer	0.00169	0.012	CcSEcCtD
Desogestrel—Dermatitis—Hydroxyurea—head and neck cancer	0.00169	0.012	CcSEcCtD
Desogestrel—Headache—Hydroxyurea—head and neck cancer	0.00168	0.012	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00167	0.0119	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.00165	0.00192	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—PIK3CA—head and neck cancer	0.00164	0.00191	CbGpPWpGaD
Desogestrel—Nausea—Hydroxyurea—head and neck cancer	0.0016	0.0113	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.00159	0.00185	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—YAP1—head and neck cancer	0.00159	0.00185	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.00157	0.00183	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.00157	0.00183	CbGpPWpGaD
Desogestrel—Urticaria—Fluorouracil—head and neck cancer	0.00154	0.0109	CcSEcCtD
Desogestrel—ESR1—Signaling by ERBB4—HRAS—head and neck cancer	0.00152	0.00176	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.00148	0.00173	CbGpPWpGaD
Desogestrel—Hypertension—Docetaxel—head and neck cancer	0.00148	0.0105	CcSEcCtD
Desogestrel—ESR1—Signaling Pathways—KISS1—head and neck cancer	0.00146	0.0017	CbGpPWpGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00145	0.0103	CcSEcCtD
Desogestrel—Hypersensitivity—Fluorouracil—head and neck cancer	0.00142	0.0101	CcSEcCtD
Desogestrel—Nervous system disorder—Docetaxel—head and neck cancer	0.00137	0.00973	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.00136	0.00159	CbGpPWpGaD
Desogestrel—Skin disorder—Docetaxel—head and neck cancer	0.00136	0.00964	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.00135	0.00157	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—AKT1—head and neck cancer	0.00134	0.00156	CbGpPWpGaD
Desogestrel—Diarrhoea—Fluorouracil—head and neck cancer	0.00132	0.0094	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.00132	0.00154	CbGpPWpGaD
Desogestrel—Vomiting—Fluorouracil—head and neck cancer	0.00123	0.00874	CcSEcCtD
Desogestrel—Rash—Fluorouracil—head and neck cancer	0.00122	0.00867	CcSEcCtD
Desogestrel—Dermatitis—Fluorouracil—head and neck cancer	0.00122	0.00866	CcSEcCtD
Desogestrel—PGR—Gene Expression—NOTCH1—head and neck cancer	0.00122	0.00142	CbGpPWpGaD
Desogestrel—Headache—Fluorouracil—head and neck cancer	0.00121	0.00861	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.0012	0.00856	CcSEcCtD
Desogestrel—ESR1—Signaling Pathways—GRP—head and neck cancer	0.0012	0.0014	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—STAT6—head and neck cancer	0.00116	0.00136	CbGpPWpGaD
Desogestrel—Nausea—Fluorouracil—head and neck cancer	0.00115	0.00816	CcSEcCtD
Desogestrel—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00114	0.00811	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.00111	0.0013	CbGpPWpGaD
Desogestrel—Abdominal pain—Docetaxel—head and neck cancer	0.0011	0.00784	CcSEcCtD
Desogestrel—ESR1—Signaling Pathways—YAP1—head and neck cancer	0.00103	0.0012	CbGpPWpGaD
Desogestrel—Hypersensitivity—Docetaxel—head and neck cancer	0.00103	0.00731	CcSEcCtD
Desogestrel—Diarrhoea—Docetaxel—head and neck cancer	0.000955	0.00679	CcSEcCtD
Desogestrel—Vomiting—Docetaxel—head and neck cancer	0.000887	0.00631	CcSEcCtD
Desogestrel—Rash—Docetaxel—head and neck cancer	0.00088	0.00625	CcSEcCtD
Desogestrel—Dermatitis—Docetaxel—head and neck cancer	0.000879	0.00625	CcSEcCtD
Desogestrel—Headache—Docetaxel—head and neck cancer	0.000874	0.00621	CcSEcCtD
Desogestrel—Nausea—Docetaxel—head and neck cancer	0.000829	0.00589	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—NOTCH1—head and neck cancer	0.000792	0.000921	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NOTCH1—head and neck cancer	0.000715	0.000832	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—MAPK3—head and neck cancer	0.000674	0.000784	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IL2—head and neck cancer	0.000545	0.000634	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CCND1—head and neck cancer	0.000531	0.000618	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTEN—head and neck cancer	0.000513	0.000596	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000465	0.000541	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—VEGFA—head and neck cancer	0.000463	0.000539	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—STAT3—head and neck cancer	0.000458	0.000533	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—AKT1—head and neck cancer	0.000454	0.000529	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MAPK3—head and neck cancer	0.000438	0.00051	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MAPK1—head and neck cancer	0.000417	0.000485	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EGFR—head and neck cancer	0.000417	0.000485	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—MAPK3—head and neck cancer	0.000395	0.00046	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CA—head and neck cancer	0.000362	0.000421	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TP53—head and neck cancer	0.00035	0.000407	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HRAS—head and neck cancer	0.000335	0.000389	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL2—head and neck cancer	0.00032	0.000372	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CCND1—head and neck cancer	0.000312	0.000363	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTEN—head and neck cancer	0.000301	0.00035	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AKT1—head and neck cancer	0.000295	0.000344	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—VEGFA—head and neck cancer	0.000272	0.000316	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—STAT3—head and neck cancer	0.000269	0.000313	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—AKT1—head and neck cancer	0.000267	0.00031	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MAPK3—head and neck cancer	0.000257	0.000299	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MAPK1—head and neck cancer	0.000245	0.000285	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EGFR—head and neck cancer	0.000245	0.000285	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	0.000212	0.000247	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TP53—head and neck cancer	0.000205	0.000239	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HRAS—head and neck cancer	0.000196	0.000228	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AKT1—head and neck cancer	0.000173	0.000202	CbGpPWpGaD
